论文信息 - Proposed rituximab biosimilar BCD‐020 versus reference rituximab for treatment of patients with indolent non‐Hodgkin lymphomas: An international multicenter randomized trial - 字舞流文

Proposed rituximab biosimilar BCD‐020 versus reference rituximab for treatment of patients with indolent non‐Hodgkin lymphomas: An international multicenter randomized trial

T. Dolai | Sergey M. Alekseev | G. Rekhtman | L. Lukavetskyy | R. Ivanov | I. Poddubnaya | K. Kaplanov | V. Attili | C. Bermúdez | A. A. Isaev | E. Chernyaeva | E. V. Chernyaeva | Aleksandr A. Isaev